期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Vascular complications after adult living donor liver transplantation:Evaluation with ultrasonography 被引量:20
1
作者 Lin Ma Qiang Lu Yan Luo 《World Journal of Gastroenterology》 SCIE CAS 2016年第4期1617-1626,共10页
Living donor liver transplantation(LDLT) has beenwidely used to treat end-stage liver disease with improvement in surgical technology and the application of new immunosuppressants. Vascular complications after liver t... Living donor liver transplantation(LDLT) has beenwidely used to treat end-stage liver disease with improvement in surgical technology and the application of new immunosuppressants. Vascular complications after liver transplantation remain a major threat to the survival of recipients. LDLT recipients are more likely to develop vascular complications because of their complex vascular reconstruction and the slender vessels. Early diagnosis and treatment are critical for the survival of graft and recipients. As a non-invasive, cost-effective and non-radioactive method with bedside availability, conventional gray-scale and Doppler ultrasonography play important roles in identifying vascular complications in the early postoperative period and during the follow-up. Recently, with the detailed vascular tracing and perfusion visualization, contrastenhanced ultrasound(CEUS) has significantly improved the diagnosis of postoperative vascular complications. This review focuses on the role of conventional grayscale ultrasound, Doppler ultrasound and CEUS for early diagnosis of vascular complications after adult LDLT. 展开更多
关键词 living DONOR liver transplantation vascularcomplications ULTRASONOGRAPHY DOPPLER ULTRASOUND CONTRAST-ENHANCED ULTRASOUND
下载PDF
Insulin sensitivity and complications in type 1 diabetes: New insights
2
作者 Petter Bjornstad Janet K Snell-Bergeon +1 位作者 Kristen J Nadeau David M Maahs 《World Journal of Diabetes》 SCIE CAS 2015年第1期8-16,共9页
Despite improvements in glucose, lipids and bloodpressure control, vascular complications remain the most important cause of morbidity and mortality in patients with type 1 diabetes. For that reason, there is a need t... Despite improvements in glucose, lipids and bloodpressure control, vascular complications remain the most important cause of morbidity and mortality in patients with type 1 diabetes. For that reason, there is a need to identify additional risk factors to utilize in clinical practice or translate to novel therapies to prevent vascular complications. Reduced insulin sensitivity is an increasingly recognized component of type 1 diabetes that has been linked with the development and progression of both micro- and macrovascular complications. Adolescents and adults with type 1 diabetes have reduced insulin sensitivity, even when compared to their non-diabetic counterparts of similar adiposity, serum triglycerides, high-density lipoprotein cholesterol, level of habitual physical activity, and in adolescents, pubertal stage. Reduced insulin sensitivity is thought to contribute both to the initiation and progression of macro- and microvascular complications in type 1 diabetes. There are currently clinical trials underway examining the benefits of improving insulin sensitivity with regards to vascular complications in type 1 diabetes. Reduced insulin sensitivity is an increasingly recognized component of type 1 diabetes, is implicated in the pathogenesis of vascular complications and is potentially an important therapeutic target to prevent vascular complications. In this review, we will focus on the pathophysiologic contribution of insulin sensitivity to vascular complications and summarize related ongoing clinical trials. 展开更多
关键词 Type 1 diabetes INSULIN sensitivity vascularcomplications HYPERFILTRATION CYSTATIN C CREATININE Glomerular FILTRATION rate
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部